MDT vs SOLV
MDT: Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain, restore health, and extend life across 150+ countries. SOLV: A diversified healthcare technology and medical products provider focused on improving patient outcomes through specialized clinical tools and healthcare software solutions.
Side-by-side fundamentals
| Metric | MDT | SOLV | Edge |
|---|---|---|---|
| Price as of 2026-08-06 close | $85.92 | $82.96 | |
| Market cap as of 2026-08-08 | $110.0B | $14.1B | |
| P/E as of 2026-08-08 | 22.77 | 9.84 | SOLV lower |
| PEG as of 2026-08-08 | 3.09 | 0.04 | SOLV lower |
| Net margin as of 2026-08-08 | +13.2% | +17.3% | SOLV higher |
| Gross margin as of 2026-08-08 | +65.3% | +54.8% | MDT higher |
| Operating margin as of 2026-08-08 | +17.8% | +23.9% | SOLV higher |
| ROE as of 2026-08-08 | +9.8% | +29.0% | SOLV higher |
| ROA as of 2026-08-08 | +5.2% | +10.1% | SOLV higher |
| Debt / equity as of 2026-08-08 | 0.57 | 1.10 | MDT lower |
| Revenue growth (YoY) as of 2026-08-08 | +8.4% | -0.9% | MDT higher |
| Revenue CAGR (3y) SEC XBRL | +5.2% | +0.8% | MDT higher |
| Dividend yield as of 2026-08-08 | +3.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-08 | 0.56 | 0.58 | |
| 1-year return as of 2026-08-06 close | -3.8% | +14.3% | SOLV higher |
Fundamentals: market data, as of 2026-08-08. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-06.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.